O	O	0	10	Regulation	Regulation	B-NP	NN	O	0	ROOT	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T1	B-Protein	14	17	fas	fas	B-NP	NN	B-protein	6	NMOD	B-protein
T1	I-Protein	17	18	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T1	I-Protein	18	24	ligand	ligand	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	25	35	expression	expression	I-NP	NN	O	2	PMOD	O
O	O	36	42	during	during	B-PP	IN	O	1	NMOD	O
O	O	43	53	activation	activation	B-NP	NN	O	12	NMOD	O
O	O	53	54	-	-	O	HYPH	O	12	NMOD	O
O	O	54	61	induced	induce	B-NP	VBN	O	12	NMOD	O
O	O	62	66	cell	cell	I-NP	NN	O	12	NMOD	O
O	O	67	72	death	death	I-NP	NN	O	7	PMOD	O
O	O	73	75	in	in	B-PP	IN	O	12	NMOD	O
O	O	76	77	T	T	B-NP	NN	B-cell_type	15	NMOD	B-cell_type
O	O	78	89	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	90	93	via	via	B-PP	IN	O	12	NMOD	O
T11	B-Entity	94	101	nuclear	nuclear	B-NP	JJ	B-protein	19	NMOD	B-protein
T11	I-Entity	102	108	factor	factor	I-NP	NN	I-protein	19	NMOD	I-protein
T11	I-Entity	109	115	kappaB	kappaB	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	115	116	.	.	O	.	O	1	P	O

O	O	118	119	T	T	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	120	124	cell	cell	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	125	133	receptor	receptor	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	134	144	engagement	engagement	I-NP	NN	O	5	SUB	O
O	O	145	154	activates	activate	B-VP	VBZ	O	0	ROOT	O
O	O	155	168	transcription	transcription	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	169	176	factors	factor	I-NP	NNS	I-protein	5	OBJ	I-protein
O	O	177	186	important	important	B-ADJP	JJ	O	7	NMOD	O
O	O	187	190	for	for	B-PP	IN	O	8	AMOD	O
T12	B-Entity	191	199	cytokine	cytokine	B-NP	NN	B-DNA	12	NMOD	B-DNA
T12	I-Entity	200	204	gene	gene	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	205	215	regulation	regulation	I-NP	NN	O	9	PMOD	O
O	O	215	216	.	.	O	.	O	5	P	O

O	O	217	229	Additionally	Additionally	B-ADVP	RB	O	7	VMOD	O
O	O	229	230	,	,	O	,	O	7	P	O
O	O	231	235	this	this	B-NP	DT	O	5	NMOD	O
O	O	236	245	signaling	signaling	I-NP	NN	O	5	NMOD	O
O	O	246	253	pathway	pathway	I-NP	NN	O	7	SUB	O
O	O	254	258	also	also	B-ADVP	RB	O	7	VMOD	O
O	O	259	264	leads	lead	B-VP	VBZ	O	0	ROOT	O
O	O	265	267	to	to	B-PP	TO	O	7	VMOD	O
O	O	268	278	activation	activation	B-NP	NN	O	12	NMOD	O
O	O	278	279	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	279	286	induced	induce	I-NP	VBN	O	12	NMOD	O
O	O	287	296	apoptosis	apoptosis	I-NP	NN	O	8	PMOD	O
O	O	297	299	in	in	B-PP	IN	O	12	NMOD	O
O	O	300	301	T	T	B-NP	NN	B-cell_type	15	NMOD	B-cell_type
O	O	302	313	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	314	318	that	that	B-NP	WDT	O	12	NMOD	O
O	O	319	321	is	be	B-VP	VBZ	O	16	SBAR	O
O	O	322	331	dependent	dependent	B-ADJP	JJ	O	17	PRD	O
O	O	332	334	on	on	B-PP	IN	O	18	AMOD	O
T2	B-Protein	335	339	FasL	FasL	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	340	353	transcription	transcription	I-NP	NN	O	23	NMOD	O
O	O	354	357	and	and	O	CC	O	23	NMOD	O
O	O	358	368	expression	expression	B-NP	NN	O	19	PMOD	O
O	O	368	369	.	.	O	.	O	7	P	O

O	O	370	374	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	375	377	we	we	B-NP	PRP	O	3	SUB	O
O	O	378	389	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	390	394	that	that	B-SBAR	IN	O	3	VMOD	O
T13	B-Entity	395	402	nuclear	nuclear	B-NP	JJ	B-protein	7	NMOD	B-protein
T13	I-Entity	403	409	factor	factor	I-NP	NN	I-protein	7	NMOD	I-protein
T13	I-Entity	410	416	kappaB	kappaB	I-NP	NN	I-protein	31	SUB	I-protein
O	O	417	418	(	(	O	(	O	12	DEP	O
T14	B-Entity	418	420	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T14	I-Entity	420	421	-	-	B-NP	HYPH	I-protein	11	P	I-protein
T14	I-Entity	421	427	kappaB	kappaB	I-NP	NN	I-protein	12	DEP	I-protein
O	O	427	428	)	)	O	)	O	7	NMOD	O
O	O	428	429	,	,	O	,	O	7	P	O
O	O	430	435	which	which	B-NP	WDT	O	7	NMOD	O
O	O	436	438	is	be	B-VP	VBZ	O	14	SBAR	O
O	O	439	447	involved	involve	I-VP	VBN	O	15	VC	O
O	O	448	450	in	in	B-PP	IN	O	16	VMOD	O
O	O	451	454	the	the	B-NP	DT	O	20	NMOD	O
O	O	455	470	transcriptional	transcriptional	I-NP	JJ	O	20	NMOD	O
O	O	471	481	regulation	regulation	I-NP	NN	O	17	PMOD	O
O	O	482	484	of	of	B-PP	IN	O	20	NMOD	O
O	O	485	489	many	many	B-NP	JJ	O	24	NMOD	O
T15	B-Entity	490	498	cytokine	cytokine	I-NP	NN	B-DNA	24	NMOD	B-DNA
T15	I-Entity	499	504	genes	gene	I-NP	NNS	I-DNA	21	PMOD	I-DNA
O	O	505	514	expressed	express	B-VP	VBN	O	24	NMOD	O
O	O	515	517	in	in	B-PP	IN	O	25	VMOD	O
O	O	518	527	activated	activate	B-NP	VBN	B-cell_type	28	NMOD	B-cell_type
O	O	528	539	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	26	PMOD	I-cell_type
O	O	539	540	,	,	O	,	O	7	P	O
O	O	541	545	also	also	B-ADVP	RB	O	31	VMOD	O
O	O	546	551	plays	play	B-VP	VBZ	O	4	SBAR	O
O	O	552	553	a	a	B-NP	DT	O	33	NMOD	O
O	O	554	558	role	role	I-NP	NN	O	31	OBJ	O
O	O	559	561	in	in	B-PP	IN	O	31	VMOD	O
O	O	562	563	T	T	B-NP	NN	O	37	NMOD	O
O	O	564	568	cell	cell	I-NP	NN	O	37	NMOD	O
O	O	569	579	activation	activation	I-NP	NN	O	41	NMOD	O
O	O	579	580	-	-	B-VP	HYPH	O	41	NMOD	O
O	O	580	587	induced	induce	B-NP	VBN	O	41	NMOD	O
T3	B-Protein	588	592	FasL	FasL	I-NP	NN	B-protein	41	NMOD	B-protein
O	O	593	603	expression	expression	I-NP	NN	O	34	PMOD	O
O	O	603	604	.	.	O	.	O	3	P	O

O	O	605	615	Inhibition	Inhibition	B-NP	NN	O	12	SUB	O
O	O	616	618	of	of	B-PP	IN	O	1	NMOD	O
T16	B-Entity	619	621	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T16	I-Entity	621	622	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T16	I-Entity	622	628	kappaB	kappaB	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	629	637	activity	activity	I-NP	NN	O	2	PMOD	O
O	O	638	640	in	in	B-PP	IN	O	1	NMOD	O
O	O	641	642	a	a	B-NP	DT	O	11	NMOD	O
O	O	643	644	T	T	I-NP	NN	B-cell_line	11	NMOD	B-cell_line
O	O	645	649	cell	cell	I-NP	NN	I-cell_line	11	NMOD	I-cell_line
O	O	650	659	hybridoma	hybridoma	I-NP	NN	I-cell_line	7	PMOD	I-cell_line
O	O	660	665	leads	lead	B-VP	VBZ	O	0	ROOT	O
O	O	666	668	to	to	B-PP	TO	O	12	VMOD	O
O	O	669	678	decreased	decrease	B-NP	VBN	O	16	NMOD	O
T4	B-Protein	679	683	FasL	FasL	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	684	694	expression	expression	I-NP	NN	O	18	NMOD	O
O	O	695	698	and	and	O	CC	O	18	NMOD	O
O	O	699	708	apoptosis	apoptosis	B-NP	NN	O	13	PMOD	O
O	O	709	713	upon	upon	B-PP	IN	O	18	NMOD	O
O	O	714	715	T	T	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	716	720	cell	cell	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	721	729	receptor	receptor	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	730	741	stimulation	stimulation	I-NP	NN	O	19	PMOD	O
O	O	741	742	.	.	O	.	O	12	P	O

O	O	743	745	We	We	B-NP	PRP	O	2	SUB	O
O	O	746	756	identified	identify	B-VP	VBD	O	0	ROOT	O
O	O	757	760	the	the	B-NP	DT	O	7	NMOD	O
T17,T18	B-Entity,B-Entity	761	763	NF	NF	I-NP	NN	B-DNA	7	NMOD	B-DNA
T17,T18	I-Entity,I-Entity	763	764	-	-	B-NP	HYPH	I-DNA	7	NMOD	I-DNA
T17,T18	I-Entity,I-Entity	764	770	kappaB	kappaB	I-NP	NN	I-DNA	7	NMOD	I-DNA
T17	I-Entity	771	775	site	site	I-NP	NN	I-DNA	2	OBJ	I-DNA
O	O	776	778	in	in	B-PP	IN	O	7	NMOD	O
O	O	779	782	the	the	B-NP	DT	O	11	NMOD	O
T5	B-Protein	783	787	FasL	FasL	I-NP	NN	B-DNA	11	NMOD	B-DNA
T19	B-Entity	788	796	promoter	promoter	I-NP	NN	I-DNA	8	PMOD	I-DNA
O	O	797	801	that	that	B-NP	WDT	O	7	NMOD	O
O	O	802	813	contributes	contribute	B-VP	VBZ	O	12	SBAR	O
O	O	814	816	to	to	B-PP	TO	O	13	VMOD	O
O	O	817	821	such	such	B-NP	JJ	O	16	NMOD	O
O	O	822	832	regulation	regulation	I-NP	NN	O	14	PMOD	O
O	O	832	833	.	.	O	.	O	2	P	O

O	O	834	836	Co	Co	B-NP	AFX	B-DNA	3	NMOD	B-DNA
O	O	836	837	-	-	I-NP	HYPH	O	3	P	O
O	O	837	847	expression	expression	B-NP	NN	O	14	SUB	O
O	O	848	850	of	of	B-PP	IN	O	3	NMOD	O
T6	B-Protein	851	854	p65	p65	B-NP	NN	O	4	PMOD	O
O	O	855	856	(	(	O	(	O	9	DEP	O
T7	B-Protein	856	859	Rel	Rel	B-NP	NN	B-protein	8	NMOD	B-protein
T7	I-Protein	860	861	A	A	I-NP	NN	I-protein	9	DEP	I-protein
O	O	861	862	)	)	O	)	O	5	NMOD	O
O	O	863	867	with	with	B-PP	IN	O	3	NMOD	O
O	O	868	871	the	the	B-NP	DT	O	13	NMOD	O
T8	B-Protein	872	876	FasL	FasL	I-NP	NN	B-DNA	13	NMOD	B-DNA
T20	B-Entity	877	885	promoter	promoter	I-NP	NN	I-DNA	10	PMOD	I-DNA
O	O	886	894	enhanced	enhance	B-VP	VBD	O	21	NMOD	O
O	O	895	898	its	its	B-NP	PRP$	O	16	NMOD	O
O	O	899	907	activity	activity	I-NP	NN	O	14	OBJ	O
O	O	907	908	,	,	O	,	O	21	P	O
O	O	909	912	and	and	O	CC	O	21	NMOD	O
O	O	913	915	co	co	B-NP	AFX	O	21	NMOD	O
O	O	915	916	-	-	I-NP	HYPH	O	21	NMOD	O
O	O	916	926	expression	expression	B-NP	NN	O	25	SUB	O
O	O	927	929	of	of	B-PP	IN	O	21	NMOD	O
O	O	930	937	IkappaB	IkappaB	B-NP	NN	B-protein	22	PMOD	B-protein
O	O	938	950	dramatically	dramatically	B-ADVP	RB	O	25	VMOD	O
O	O	951	960	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	961	964	the	the	B-NP	DT	O	29	NMOD	O
T21	B-Entity	965	974	inducible	inducible	I-NP	JJ	B-DNA	29	NMOD	B-DNA
T21	I-Entity	975	983	promoter	promoter	I-NP	NN	I-DNA	29	NMOD	I-DNA
O	O	984	992	activity	activity	I-NP	NN	O	25	OBJ	O
O	O	992	993	.	.	O	.	O	25	P	O

O	O	994	996	In	In	B-PP	IN	O	10	VMOD	O
O	O	997	1005	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	1005	1006	,	,	O	,	O	10	P	O
O	O	1007	1010	the	the	B-NP	DT	O	6	NMOD	O
O	O	1011	1024	transcription	transcription	I-NP	NN	B-protein	6	NMOD	B-protein
O	O	1025	1031	factor	factor	I-NP	NN	I-protein	8	NMOD	I-protein
T22	B-Entity	1032	1034	AP	AP	I-NP	NN	B-protein	8	NMOD	B-protein
T22	I-Entity	1034	1035	-	-	B-NP	HYPH	I-protein	10	SUB	I-protein
T22	I-Entity	1035	1036	1	1	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	1037	1039	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1040	1043	not	not	I-VP	RB	O	10	VMOD	O
O	O	1044	1052	required	require	I-VP	VBN	O	10	VC	O
O	O	1053	1056	for	for	B-PP	IN	O	12	VMOD	O
O	O	1057	1067	activation	activation	B-NP	NN	O	19	NMOD	O
O	O	1067	1068	-	-	B-NP	HYPH	O	19	NMOD	O
O	O	1068	1075	induced	induce	I-NP	VBN	O	19	NMOD	O
T9	B-Protein	1076	1080	FasL	FasL	I-NP	NN	B-DNA	19	NMOD	B-DNA
T23	B-Entity	1081	1089	promoter	promoter	I-NP	NN	I-DNA	19	NMOD	I-DNA
O	O	1090	1098	activity	activity	I-NP	NN	O	13	PMOD	O
O	O	1098	1099	.	.	O	.	O	10	P	O

O	O	1100	1105	These	These	B-NP	DT	O	2	NMOD	O
O	O	1106	1113	results	result	I-NP	NNS	O	3	SUB	O
O	O	1114	1120	define	define	B-VP	VBP	O	0	ROOT	O
O	O	1121	1122	a	a	B-NP	DT	O	5	NMOD	O
O	O	1123	1127	role	role	I-NP	NN	O	3	OBJ	O
O	O	1128	1131	for	for	B-PP	IN	O	5	NMOD	O
T24	B-Entity	1132	1134	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T24	I-Entity	1134	1135	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T24	I-Entity	1135	1141	kappaB	kappaB	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	1142	1144	in	in	B-PP	IN	O	5	NMOD	O
O	O	1145	1154	mediating	mediate	B-VP	VBG	O	10	PMOD	O
T10	B-Protein	1155	1159	FasL	FasL	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	1160	1170	expression	expression	I-NP	NN	O	11	OBJ	O
O	O	1171	1177	during	during	B-PP	IN	O	11	VMOD	O
O	O	1178	1179	T	T	B-NP	NN	O	17	NMOD	O
O	O	1180	1184	cell	cell	I-NP	NN	O	17	NMOD	O
O	O	1185	1195	activation	activation	I-NP	NN	O	14	PMOD	O
O	O	1195	1196	.	.	O	.	O	3	P	O
